Health Canada has issued a stern warning to licensed commercial growers across Canada, telling them to revamp their advertising — or else, they might receive a suspension or revocation of their licenses. The problem? Apparently they're making marijuana look too good.
British pharmaceutical company GW Pharmaceuticals has developed a medical marijuana drug called Sativex. The drug is delivered orally via a spray pump, and is the first of its kind to be produced by extracting high-inducing cannabinoids like THC (pot's primary psychoactive ingredient) from the cannabis plant itself.
One reason why medical professionals have lobbied tirelessly to legalize medical marijuana is that the drug can be a powerful painkiller. Now researchers have invented a drug that acts just like marijuana, but never goes to your head.